SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-311319
Filing Date
2021-10-28
Accepted
2021-10-28 16:16:47
Documents
13
Period of Report
2021-10-22
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d162622d8k.htm   iXBRL 8-K 24839
  Complete submission text file 0001193125-21-311319.txt   187203

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nuvb-20211022.xsd EX-101.SCH 3945
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nuvb-20211022_def.xml EX-101.DEF 14232
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvb-20211022_lab.xml EX-101.LAB 23489
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvb-20211022_pre.xml EX-101.PRE 15266
6 EXTRACTED XBRL INSTANCE DOCUMENT d162622d8k_htm.xml XML 5432
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

IRS No.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39351 | Film No.: 211358445
SIC: 2834 Pharmaceutical Preparations